Diabetic patients using subcutaneous injections of Symlin (pramlintide), as well as diet, exercise and lifestyle changes, lost an average of 7.9 pounds in six months versus 4.6 pounds in those given injections of a placebo, a increase of 3.3 lbs—a small increase in weight loss—according to a new study from the makers of Symlin (pramlintide).
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.